The Truveta collaboration will extend Regeneron Genetics Center’s ® (RGC TM) world-leading DNA sequence-linked healthcare database (now including almost three million de-identified patient volunteers) ...

(Reuters) -Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of DNA data from ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s privacy ...

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, promising to honor existing privacy protections and continue consumer services ...

Did you spit in a tube for 23andMe? If so, your genetic data may soon be handed over to a new company — Regeneron. Just four years ago, when 23andMe went public, the company was valued at $6 billion.

(Reuters) - Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of ...